FXAIX
Price
$218.74
Change
+$1.84 (+0.85%)
Updated
Jul 3 closing price
Net Assets
665.84B
RICCX
Price
$63.24
Change
+$0.60 (+0.96%)
Updated
Jul 3 closing price
Net Assets
165.92B
Interact to see
Advertisement

FXAIX vs RICCX

Header iconFXAIX vs RICCX Comparison
Open Charts FXAIX vs RICCXBanner chart's image
Fidelity 500 Index
Price$218.74
Change+$1.84 (+0.85%)
VolumeN/A
Net Assets665.84B
American Funds Invmt Co of Amer R3
Price$63.24
Change+$0.60 (+0.96%)
VolumeN/A
Net Assets165.92B
FXAIX vs RICCX Comparison Chart in %
Loading...
View a ticker or compare two or three
VS
FXAIX vs. RICCX commentary
Jul 05, 2025

To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is FXAIX is a Buy and RICCX is a Buy.

Interact to see
Advertisement
FUNDAMENTALS
Fundamentals
FXAIX has more cash in the bank: 666B vs. RICCX (166B). FXAIX pays higher dividends than RICCX: FXAIX (1.20) vs RICCX (0.61). FXAIX was incepted earlier than RICCX: FXAIX (14 years) vs RICCX (23 years). RICCX (0.91) is less costly to investors than FXAIX (0.01). RICCX is a more actively managed with annual turnover of: 32.00 vs. FXAIX (2.00). FXAIX has a lower initial minimum investment than RICCX: FXAIX (0) vs RICCX (250). FXAIX annual gain was more profitable for investors over the last year : 13.95 vs. RICCX (10.75). FXAIX return over 5 years is better than : 114.43 vs. RICCX (71.74).
FXAIXRICCXFXAIX / RICCX
Total Expense Ratio0.010.912%
Annual Report Gross Expense Ratio0.010.912%
Fund Existence14 years23 years-
Gain YTD6.56310.64862%
Front LoadN/AN/A-
Min. Initial Investment0250-
Min. Initial Investment IRAN/AN/A-
Net Assets666B166B401%
Annual Yield % from dividends1.200.61196%
Returns for 1 year13.9510.75130%
Returns for 3 years70.2857.68122%
Returns for 5 years114.4371.74160%
Returns for 10 years230.7277.96296%
View a ticker or compare two or three
Interact to see
Advertisement
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
STOCK / NAMEPrice $Chg $Chg %
NMRA0.820.04
+5.04%
Neumora Therapeutics
BOOT164.934.74
+2.96%
Boot Barn Holdings
HSII48.521.10
+2.32%
Heidrick & Struggles International
WBA11.47-0.02
-0.17%
Walgreens Boots Alliance
KAPA0.65-0.04
-6.33%
Kairos Pharma Ltd.